Physician profile
Christopher Curzon
NPI 1952582074
$46,408.89
in general payments reported to CMS, 2019-2025
11 companies · $3,439 in 2025
The $3,439 reported for 2025 was more than what 90% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $185 · 2021: $370 · 2022: $616 · 2023: $25K · 2024: $16K · 2025: $3,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $15K · Food and Beverage: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,628.29 |
| Travel and Lodging | $14,960.50 |
| Food and Beverage | $2,347.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integer Holdings Corporation | $39,219.95 | 2023-2024 | Amplatzer Wire, Pv-Tracker Guidewire, Amplatzer Guidewire |
| Medtronic, INC. | $5,122.10 | 2021-2025 | Harmony |
| Karl Storz Endoscopy-America | $1,073.84 | 2025 | |
| Medtronic Vascular, INC. | $390.52 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $163.61 | 2021-2024 | Artis Pheno |
| Abbott Laboratories | $103.47 | 2020-2024 | Amplatzer Piccolo, Amplatzer |
| Terumo Medical Corporation | $92.81 | 2023-2025 | Azur Cx Detachable |
| W. L. Gore & Associates, INC. | $85.51 | 2019-2021 | |
| Boston Scientific Corporation | $63.16 | 2022-2024 | Versacross Steerable Access Solution |
| Abiomed | $60.13 | 2025 | |
| Renata Medical, INC. | $33.79 | 2025 | Minima Stent System - 6mm, Minima Stent System - 8mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Curzon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.